Saturday 17 October 2026
Export HSIC’s income statement to Excel — free account
Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
86.38
0.61
−0.70%
Follow HSIC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 10.20% | 10.03% | 10.04% | 9.58% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | 5 | 5 | 5 | |
| 3.62% | 3.63% | 3.71% | 3.60% | ||
ROIC |
6.97% | 6.71% | 6.71% | 6.64% | |
Return on Tangible Assets |
23.29% | 21.74% | 21.43% | 21.15% | |
Average Days of Receivables |
47.31 | 46.88 | 45.71 | 49.17 | |
Free Cash Flow per Share |
5.02 | 3.87 | 4.74 | 3.35 | |
Free Cash Flow |
569.00 | 445.00 | 573.00 | 403.00 | |
Capital Expenditures |
(131.00) | (133.00) | (139.00) | (132.00) | |
| Other line items | |||||
Cash ROIC |
8.87% | 6.93% | 8.96% | 6.35% | |
Accounts Receivable Turnover |
7.98 | 8.12 | 8.42 | 7.60 | |
Accounts Payable Turnover |
9.10 | 9.44 | 8.58 | 8.64 | |
Inventory Turnover |
4.71 | 4.78 | 4.76 | 4.86 | |
Average Days of Payables |
44.35 | 41.34 | 46.39 | 42.43 | |
Days of Inventory on Hand |
80.45 | 79.83 | 80.49 | 78.39 | |
Tax Rate |
(0.24) | (0.24) | (0.24) | (0.24) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
23.58% | 23.57% | 23.39% | 23.30% | |
Share Based Compensation of Revenue |
0.29% | 0.28% | 0.30% | 0.29% | |
Interest Coverage |
4.28 | 4.29 | 4.35 | 4.42 | |
Operating CF/Net income |
1.74 | 1.46 | 1.79 | 1.37 | |
Depreciation/Fixed assets |
0.53 | 0.51 | 0.50 | 0.53 | |
Capex/Depreciation |
(0.40) | (0.42) | (0.45) | (0.42) | |
Revenue per Share |
119.89 | 116.44 | 109.13 | 107.64 | |
Operating CF per Share |
6.17 | 5.03 | 5.89 | 4.45 | |
Capex per Share |
(1.15) | (1.16) | (1.15) | (1.10) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates